JRC Publications Repository

JRC Publications Repository >

Browsing by Author BRUCHERTSEIFER Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 50 to 69 of 92
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2010Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN AlfredArticles in Journals
2013Measurement and modelling of the cross sections for the reaction 230Th(3He,3n)230UMORGENSTERN Alfred; ABBAS Kamel; SIMONELLI Federica; CAPOTE NOY R.; SIN M.; ZIELINSKA B.; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2012Measurement of the 225Ac half-lifePOMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank, et alArticles in Journals
2014Microbicidal Power of Alpha Radiation in Sterilizing Germinating Bacillus anthracis SporesRIVERA J.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; KEARNEY John; TURNBOUGH Charles; DADACHOVA E.; Casadevall ArturoArticles in Journals
2014Optimizing energy window settings for microSPECT of 213BiDE SWART J; SEGBERS M; CHAN Ho-Sze; MORGENSTERN Alfred; KOELEWIJN S.j.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.Contributions to Conferences
2014Optimizing labeling conditions of 213Bi somatostatin analogues for receptor mediated process in preclinical modelsCHAN Ho-Sze; DE BLOIS Erik; KONIJNENBERG M.w.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; BREEMAN Wouter; DE JONG MarionContributions to Conferences
2012Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.Articles in Journals
2012Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility studyTHIJSEN L.; SCHAART D.r.; DE VRIES D.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DENKOVA A.g.Articles in Journals
2008Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231PaMORGENSTERN Alfred; LEBEDA O.; STURSA J.; BRUCHERTSEIFER Frank; CAPOTE R.; MCGINLEY John; RASMUSSEN Gert; SIN M.; ZIELINSKA B.; APOSTOLIDIS ChristosArticles in Journals
2008Production of Alpha Emitters for Targeted Alpha TherapyMORGENSTERN Alfred; ABBAS Kamel; BRUCHERTSEIFER Frank; APOSTOLIDIS ChristosArticles in Journals
2008Production of Alpha Emitting Radionuclides for Nuclear MedicineMORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER FrankArticles in books
2008Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformansBRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy Is Effective Against High-Inoculum Cryptococcus Neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal CellsBRYAN R. A.; JIANG Z.; HUANG X.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; CASADEVALL A.; DADACHOVA E.Articles in Journals
2010Radioimmunotherapy is More Effective than Antifungal Treatment in Experimental Cryptococcal InfectionBRYAN R. A.; JIANG Z.; HOWELL Roberta; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.Articles in Journals
2013Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian CellsBRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.Articles in Journals
2009Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAbPFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.Contributions to Conferences
2012Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histonesDADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN AContributions to Conferences
2009Radiolabeled Antibodies to Bacillus Anthracis Toxins are Bactericidal and Partially Therapeutic in Experimental Murine AnthraxRIVERA J.; NAKOUZI A.s.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DADACHOVA E.Articles in Journals
2012Radiopeptidtherapie des Ovarialkarzinoms mit Alphastrahlern: Verbesserte Tumorkontrolle durch Kombination von 213Bi-DTPA-F3 mit Taxol bei irreversiblen Zellzyklusarrest von Ovarialkarzinomzellen in der G2/M-PhaseSEIDL C.; VALLON M.; BLECHERT B.; GÄRTNER Florian; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; ESSLER M.Contributions to Conferences
Showing results 50 to 69 of 92

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top